Tolerance.ca
Director / Editor: Victor Teboul, Ph.D.
Looking inside ourselves and out at the world
Independent and neutral with regard to all political and religious orientations, Tolerance.ca® aims to promote awareness of the major democratic principles on which tolerance is based.

The FDA approved a new drug to treat Alzheimer's, but Medicare won't always pay for it – a doctor explains what researchers know about Biogen's Aduhelm

By Andrew Williams, Assistant Professor of Emergency Medicine, Albert Einstein College of Medicine
Share this article
Medicare finalized its decision to restrict its coverage of Aduhelm, Biogen’s new Alzheimer’s disease drug, on April 8, 2022.

The decision means only patients who have enrolled in clinical trials will…The Conversation


Read complete article

© The Conversation -


Follow us on ...
Facebook Twitter